This video shows multiple TB survivors talk about the importance of latent TB infection testing and treatment. A TB control professional describes his work helping patients begin and complete treatment for latent TB infection.
These LTBI information sheets provide treatment information for 3HP and Rifampin. Remember to reinforce that the BCG vaccine does not cause a false positive TB blood test, as it can in some cases with the TB skin test. This is also noted in these documents.
These handouts are available in several other languages by the Minnesota Department of Health. Links to get to those documents can be found under the Minnesota Department of Health link below.
The third document provides information on who should be tested for latent tuberculosis infection (LTBI).
This site has foreign language resources that includes the Foreign Language TB Patient Information document that was created by the Michigan Department of Health and Human Services (MDHHS) TB Control Program with links to many foreign language resources.
The CDC has publications that covers latent tuberculosis infection (LTBI), and other TB topics. Patient education materials can be found in:
The CDC also offers Provider Resources that provides CDC guidance on testing and treating latent tuberculosis infection (LTBI).
The Stop TB poster helps to explain how TB is spread and the difference between active TB disease and LTBI in English and Spanish.
The Minnesota Department of Health provides fact sheets that explain TB blood testing, also known as an Interferon Gamma Release Assay (IGRA). There are currently two blood tests that look for TB infection, QuantiFERON ®-TB and T-SPOT®.TB
The Minnesota Department of Health has information on TB blood tests in general that explains LTBI, why individuals should be tested, as well as LTBI treatment information specifically for Isoniazid, Rifampin, and 3HP (Isoniazid and Rifapentine) in:
There are also treatment regimen fact sheets for Isoniazid, Rifampin, and 3HP (Isoniazid and Rifapentine) in: